FDMT | 4D MOLECULAR THERAPEUTICS IN

CUSIP: 35104E100

0 Funds Holding

0 Total Shares

$0 Total Value

$462M

Market Cap

—

P/E Ratio

-2.3

Forward P/E

$-3.75

EPS (TTM)

—

Dividend Yield

$305M

Cash

$25M

Total Debt

57M

Shares Out

$2.23

$12.34

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
No funds currently hold this stock.

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2024-Q3
Viking Global Investors	SELL	EXIT	—	—	$15.51
2024-Q1
Viking Global Investors	SELL	-38.7%	2.9M	$94M	$27.39
2023-Q2
Viking Global Investors	BUY	+21.6%	4.8M	$87M	$18.06
2020-Q4
Viking Global Investors	BUY	NEW	3.9M	$163M	$40.50

6 Months Insider Sentiment

100%

Buy $0 Sell $131K

0 Buys

8 Sells

-131K Net

0 Grants

Largest

$32K Bizily

$24K Bizily

$19K Bizily

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Dec 20, 2025	Ashoo Gupta	VP, Finance and Controller	SELL	79	$8.68	$686
Dec 20, 2025	Ashoo Gupta	VP, Finance and Controller	SELL	310	$8.68	$3K
Dec 16, 2025	Scott Bizily	Chief Legal Officer	SELL	1.6K	$10.90	$18K
Dec 16, 2025	Scott Bizily	Chief Legal Officer	EXERCISE	1.6K	$4.14	$7K
Dec 12, 2025	Charles Theuer	Director	EXERCISE	9.3K	$1.14	$11K
Nov 17, 2025	Scott Bizily	Chief Legal Officer	SELL	1.6K	$10.59	$17K
Nov 17, 2025	Scott Bizily	Chief Legal Officer	EXERCISE	1.6K	$4.14	$7K
Oct 24, 2025	Scott Bizily	Chief Legal Officer	EXERCISE	1.1K	$6.49	$7K
Oct 24, 2025	Scott Bizily	Chief Legal Officer	SELL	2.7K	$12.00	$32K
Oct 16, 2025	Scott Bizily	Chief Legal Officer	SELL	1.6K	$10.17	$17K
Oct 16, 2025	Scott Bizily	Chief Legal Officer	EXERCISE	1.6K	$4.14	$7K
Oct 09, 2025	Scott Bizily	Chief Legal Officer	SELL	2.4K	$10.00	$24K
Sep 23, 2025	Scott Bizily	Chief Legal Officer	SELL	2.4K	$8.00	$19K

Institutional Ownership of 4D MOLECULAR THERAPEUTICS IN